Angioedema due to the new oral anticoagulant rivaroxaban

Angioedema due to the new oral anticoagulant rivaroxaban

Bibliographic Details
Main Authors:	Cihan Altin, Ovgu Anil Yakin Ozturkeri, Esin Gezmis, Ulku Askin
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-01-01
Series:	Annals of Cardiac Anaesthesia
Online Access:	http://www.annals.in/article.asp?issn=0971-9784;year=2014;volume=17;issue=2;spage=173;epage=174;aulast=Altin

Similar Items

Piezogenic pedal papules with mitral valve prolapse
by: Cihan Altin, et al.
Published: (2016-01-01)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
by: Turpie AGG
Published: (2014-03-01)

A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting
by: Frydman, Galit H., et al.
Published: (2020)

Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
by: Dimitar Sajkov, et al.
Published: (2015-07-01)

Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
by: Dimitar Sajkov, et al.
Published: (2015-01-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
by: Leonie Stolz, et al.
Published: (2017-07-01)

CHANGE OF ANTICOAGULANT EFFECT OF RIVAROXABAN DURING A DAY
by: I. V. Gel’Tser, et al.
Published: (2015-08-01)

Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
by: Abbas‎ Ghaysouri, et al.
Published: (2020-09-01)

Rivaroxaban induced retro peritoneal hematoma: a rare complication of direct oral anticoagulants (DOACs)
by: Bouaiyda Ayoub, et al.
Published: (2020-07-01)

Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
by: Xiehui Chen, et al.
Published: (2021-10-01)

Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants through a Case Report
by: Naveen Nannapaneni, et al.
Published: (2014-01-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY OF PULMONARY EMBOLISM: FOCUS ON RIVAROXABAN
by: O. V. Averkov, et al.
Published: (2017-11-01)

Angioedema Due to Lamiaceae Allergy
by: Selçuk Yazıcı, et al.
Published: (2018-02-01)

Angiodema due to oral acitretin and isotretinoin Angioedema por acitretina e isotretinoína oral
by: Roberto Rheingantz da Cunha Filho, et al.
Published: (2011-08-01)

A Low Rivaroxaban Plasma Level May Indicate Anticoagulation Undertreatment
by: Simone Lorenzo Romano, et al.
Published: (2018-10-01)

Idiosyncratic Liver Injury due to Rivaroxaban
by: Aneesh Cherakulam Ratheendran, et al.
Published: (2017-12-01)

Etude d'un anticoagulant oral (le rivaroxaban) sur les paramètres hémostatiques de chiens en santé
by: Conversy, Bérénice
Published: (2015)

Angioedema due to Systemic Isotretinoin Therapy
by: Pelin Üstüner
Published: (2014-01-01)

Anticoagulation intensity of rivaroxaban for stroke patients at a special low dosage in Japan.
by: Takuya Okata, et al.
Published: (2014-01-01)

Simulation of anticoagulation in atrial fibrillation patients with rivaroxaban—from trial to target population
by: Chi Zhang, et al.
Published: (2021-09-01)

Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
by: Jayasree Pillarisetti, et al.
Published: (2020-11-01)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
by: Helen Mani, et al.
Published: (2015-01-01)

MINIMISATION OF BLEEDING RISKS DUE TO DIRECT ORAL ANTICOAGULANTS
by: Ovidiu Vornicu, et al.
Published: (2016-07-01)

Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
by: Colleen A McHorney, et al.
Published: (2018-01-01)

Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
by: A T Cohen, et al.
Published: (2016-01-01)

Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018-09-01)

Direct oral anticoagulants: A new chapter in anticoagulation therapy
by: Stepanović-Petrović Radica, et al.
Published: (2020-01-01)

Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice
by: Dan Yang, et al.
Published: (2017-03-01)

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE
by: Walter Ageno, et al.
Published: (2017-06-01)

Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
by: A T Cohen, et al.
Published: (2016-01-01)

Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
by: Oliver Königsbrügge, et al.
Published: (2019-10-01)

Pediatric hereditary angioedema due to C1-inhibitor deficiency
by: Farkas Henriette
Published: (2010-07-01)

Antidotes for the new oral anticoagulant drugs!
by: Jawed Fareed, et al.
Published: (2019-01-01)

New oral anticoagulants and their reversal agents
by: Crista L. Laslo, et al.
Published: (2018-10-01)

New oral anticoagulants in the prevention of stroke
by: Konrad Jarząbek, et al.
Published: (2013-10-01)

New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

DENTAL IMPLICATIONS OF THE NEW ORAL ANTICOAGULANTS
by: Cringuta Paraschiv, et al.
Published: (2016-01-01)

New oral anticoagulants in atrial fibrillation
by: L. Sumithra, et al.
Published: (2014-11-01)

Cannot write session to /tmp/vufind_sessions/sess_2hf35chedrufa23v33q5riv80v